GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.Molner AS (OTSE:MOLNR) » Definitions » Short-Term Capital Lease Obligation

J.Molner AS (OTSE:MOLNR) Short-Term Capital Lease Obligation : €0.00 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is J.Molner AS Short-Term Capital Lease Obligation?

J.Molner AS's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was €0.00 Mil.


J.Molner AS Short-Term Capital Lease Obligation Historical Data

The historical data trend for J.Molner AS's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.Molner AS Short-Term Capital Lease Obligation Chart

J.Molner AS Annual Data
Trend Dec21 Dec22 Dec23
Short-Term Capital Lease Obligation
- - -

J.Molner AS Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Short-Term Capital Lease Obligation - - - - -

J.Molner AS Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.


J.Molner AS Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of J.Molner AS's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


J.Molner AS (OTSE:MOLNR) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Akadeemia tee 21/5, Harju maakond, Tallinn, EST, 12618
J.Molner AS is an Estonia-based company. The company is engaged in research and development in the field of biotechnology. The activities of the Company are divided into two fields: 1) Chemistry analytical and development services for third parties; 2) Development of the Company's own line of generic pharmaceuticals.

J.Molner AS (OTSE:MOLNR) Headlines

No Headlines